Global Coronavirus (COVID-19) Vaccine Market Research Report 2021: Market is Expected to Grow at a Robust Rate to Reach $91.3 Billion
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Global Coronavirus Vaccine Market, By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine Type, By Product Type, By Route of Administration, By Patient Type, By End User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.
The Global Coronavirus Vaccine Market is expected to grow at a robust rate in value terms to reach USD 91325.46 million by the end of 2021.
The ongoing pandemic novel coronavirus disease (COVID-19) is caused due to SARS-COV-2 and generally spreads from animals to humans and then from humans to humans.
The Global Coronavirus Vaccine Market is expected to grow at a robust rate during the forecast period. The Global Coronavirus Vaccine Market is driven by the increasing prevalence of this disease across different parts of the globe. This has increased the need to protect the world from the virus, thereby increased sales of coronavirus vaccine through 2026.
Furthermore, increasing research and development activities by various pharmaceutical & biotechnology players for the development of potential vaccines is anticipated to foster the market growth. According to WHO, there are more than 70 coronavirus vaccines under development by different companies and organizations.
Currently, mRNA-based vaccine named Moderna COVID-19 Vaccine (mRNA-1273), adenovirus-based vaccine named COVID-19 Vaccine AstraZeneca (AZD1222) also known as Covishield in India and Sputnik V which constitutes recombinant adenovirus vaccine which is developed by Gamaleya Research Institute, Russia are being used for vaccination among adults.
The vaccine developed by Moderna, Inc., Pfizer Inc., AstraZeneca PLC are leading the race and is currently administered to entire population. T-COVIDTM, AdCOVID and COVI-VAC are intranasal COVID-19 vaccines which are under pre-clinical and phase 1 trials.
The Global Coronavirus Vaccine Market is segmented based on infection type, vaccine type, product type, route of administration, patient type, end-user, company, and region. Based on infection type, the market can be categorized into SARS-CoV-2, SARS-CoV and MERS-CoV. The SARS-CoV-2 segment is expected to dominate the market since this infection or virus is the primary cause of the pandemic.
Regionally, the Global Coronavirus Vaccine Market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, Asia-Pacific is expected to witness significant growth during the forecast period in the overall coronavirus vaccine market.
Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.
Major players include
Moderna, Inc
Pfizer Inc
Johnson & Johnson SA
Sinopharm Group Company Ltd
AstraZeneca PLC
Serum Institute of India Pvt Ltd
Bharat Biotech International Ltd
Sinovac Biotech Ltd
Sanofi SA
GlaxoSmithKline PLC
Novavax, Inc
Airway Therapeutics, Inc
Cadila Healthcare Ltd
CanSino Biologics Inc
Mitsubishi Chemical Holdings Corporation
Eubiologics Co Ltd
United Biomedical Inc
Merck & Co, Inc
CureVac NV
Inovio Pharmaceuticals, Inc
Report Scope:
Years considered for this report:
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022-2026
Global Coronavirus Vaccine Market, By Infection Type:
SARS-CoV-2
SARS-CoV
MERS-CoV
Global Coronavirus Vaccine Market, By Vaccine Type:
Virus Vaccine
Viral Vector Vaccine
Nucleic Acid Vaccine
Protein Based Vaccine
Others
Global Coronavirus Vaccine Market, By Product Type:
Monovalent Vaccine
Multivariant Vaccine
Global Coronavirus Vaccine Market, By Route of Administration:
Intramuscular
Oral
Intranasal
Global Coronavirus Vaccine Market, By Patient Type:
Adult
Pediatric
Global Coronavirus Vaccine Market, By End-User:
Hospitals
Clinics
Research Institutes
Others
Global Coronavirus Vaccine Market, By Region:
North America
United States
Mexico
Canada
Europe
United Kingdom
Germany
France
Italy
Spain
Asia-Pacific
China
India
Singapore
Japan
South Korea
Hong Kong
Australia
Thailand
South America
Brazil
Argentina
Colombia
Middle East & Africa
UAE
Saudi Arabia
Kuwait
South Africa
For more information about this report visit https://www.researchandmarkets.com/r/rwlbls
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900